David Freitas de Lucena

Results of the COVID-19 mental health international for the general population (COMET-G) study

Konstantinos Ν. Fountoulakis, Grigorios N. Karakatsoulis, Seri Abraham et al. · European Neuropsychopharmacology · 2021 · 138 citations · Full text

Medicine, Health Sciences, Psychiatry +5

Evidences for a progressive microglial activation and increase in iNOS expression in rats submitted to a neurodevelopmental model of schizophrenia: Reversal by clozapine

Bruna Mara Machado Ribeiro, Marta Regina Santos do Carmo, Rosemayre Souza Freire et al. · Schizophrenia Research · 2013 · 124 citations

Medicine, Neurobiology, Neuroscience +16

Prevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: Possible involvement of antioxidant and nitrergic pathways

Aline Santos Monte, Greicy Coelho de Souza, Roger S. McIntyre et al. · Journal of Psychopharmacology · 2013 · 123 citations · Full text

Medicine, Neurobiology, Pharmacology +16

Improvement of Negative and Positive Symptoms in Treatment-Refractory Schizophrenia

David Freitas de Lucena, Brisa S. Fernandes, Michael Berk et al. · The Journal of Clinical Psychiatry · 2009 · 117 citations

Medicine, Pharmacotherapy, Psychiatry +16

Antidepressant-like effect of nitric oxide synthase inhibitors and sildenafil against lipopolysaccharide-induced depressive-like behavior in mice

V.S. TOMAZ, R.C. Cordeiro, A.M.N. Costa et al. · Neuroscience · 2014 · 104 citations · Full text

Medicine, Neuroscience, Pharmacology +16